Because serum asprosin level in PCOS patients does not differ from that of healthy individuals, the observed dysregulation of asprosin in T2D patients could be disease-specific even though PCOS patients share similar glucose/insulin and lipid profiles with T2D patients. Here, INS is linked to type 2 diabetes mellitus.